These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24657288)

  • 1. Ferroportin-encapsulated nanoparticles reduce infection and improve immunity in mice infected with Leishmania major.
    Rafiee A; Riazi-Rad F; Darabi H; Khaze V; Javadian S; Ajdary S; Bahrami F; Alimohammadian MH
    Int J Pharm; 2014 May; 466(1-2):375-81. PubMed ID: 24657288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct strains of Leishmania major induce different cytokine mRNA expression in draining lymph node of BALB/c mice.
    Asadpour A; Riazi-Rad F; Khaze V; Ajdary S; Alimohammadian MH
    Parasite Immunol; 2013 Jan; 35(1):42-50. PubMed ID: 23106526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.
    Ribeiro TG; Franca JR; Fuscaldi LL; Santos ML; Duarte MC; Lage PS; Martins VT; Costa LE; Fernandes SO; Cardoso VN; Castilho RO; Soto M; Tavares CA; Faraco AA; Coelho EA; Chávez-Fumagalli MA
    Int J Nanomedicine; 2014; 9():5341-53. PubMed ID: 25429219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
    Hoseini MH; Moradi M; Alimohammadian MH; Shahgoli VK; Darabi H; Rostami A
    Parasitol Int; 2016 Apr; 65(2):99-104. PubMed ID: 26518128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F₁ cross-breed between susceptible BALB/c and resistant Swiss mice infected with Leishmania major exhibit an intermediate phenotype for lesion sizes and type 1 cytokines but show low level of total IgG antibodies.
    Kiige SG; Mutiso JM; Laban LT; Khayeka-Wandabwa C; Anjili CO; Ingonga J; Gicheru MM
    Scand J Immunol; 2014 May; 79(5):283-91. PubMed ID: 24498914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    Belosevic M; Finbloom DS; Van Der Meide PH; Slayter MV; Nacy CA
    J Immunol; 1989 Jul; 143(1):266-74. PubMed ID: 2499629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes.
    Felizardo TC; Toma LS; Borges NB; Lima GM; Abrahamsohn IA
    Parasitology; 2007 Nov; 134(Pt 12):1699-707. PubMed ID: 17655808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms.
    Yang SJ; Lin FH; Tsai HM; Lin CF; Chin HC; Wong JM; Shieh MJ
    Biomaterials; 2011 Mar; 32(8):2174-82. PubMed ID: 21163518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis.
    Mahmoudzadeh-Niknam H; Kiaei SS; Iravani D
    Korean J Parasitol; 2007 Dec; 45(4):247-53. PubMed ID: 18165706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.
    Abdossamadi Z; Seyed N; Zahedifard F; Taheri T; Taslimi Y; Montakhab-Yeganeh H; Badirzadeh A; Vasei M; Gharibzadeh S; Rafati S
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006123. PubMed ID: 29253854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chitosan-alginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells.
    Yang SJ; Chang SM; Tsai KC; Chen WS; Lin FH; Shieh MJ
    J Gene Med; 2010 Feb; 12(2):168-79. PubMed ID: 19943342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy.
    Kanwar JR; Mahidhara G; Kanwar RK
    Nanomedicine (Lond); 2012 Oct; 7(10):1521-50. PubMed ID: 22734611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
    Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
    Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
    J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
    Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
    J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.